Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20744 | 25763184 | Microbiome | 16S gut community of the Cameron County Hispanic Cohort. | 2015 | Details |
| A20746 | 25759243 | Toxicol Appl Pharmacol | Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction. | 2015 | Details |
| A20758 | 25753407 | Obes Rev | Paediatric non-alcoholic fatty liver disease: an overview. | 2015 | Details |
| A20763 | 25748419 | Life Sci | Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice. | 2015 | Details |
| A20767 | 25745505 | Nutr Metab (Lond) | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice. | 2015 | Details |
| A20769 | 25745056 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. | 2015 | Details |
| A20777 | 25741071 | Radiol Bras | Sonographic evaluation of visceral and subcutaneous fat in obese children. | 2015 | Details |
| A20783 | 25736377 | EMBO J | Interrupting synoviolin play at the ER: a plausible action to elevate mitochondrial energetics and silence obesity. | 2015 | Details |
| A20789 | 25733100 | J Gastroenterol | Biphasic effect of alcohol intake on the development of fatty liver disease. | 2015 | Details |
| A20794 | 25729888 | J Pediatr Gastroenterol Nutr | Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20796 | 25729707 | Diabetes Metab J | Hepatokines as a Link between Obesity and Cardiovascular Diseases. | 2015 | Details |
| A20797 | 25729601 | Curr Health Sci J | Non-alcoholic Fatty liver disease in children. | 2014 | Details |
| A20799 | 25729475 | World J Hepatol | Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. | 2015 | Details |
| A20801 | 25729297 | J Sports Sci Med | Physical Activity is Related to Fatty Liver Marker in Obese Youth, Independently of Central Obesity or Cardiorespiratory Fitness. | 2015 | Details |
| A20803 | 25727012 | Biochem Biophys Res Commun | Endoplasmic reticulum stress induces up-regulation of hepatic β-Klotho expression through ATF4 signaling pathway. | 2015 | Details |
| A20806 | 25724480 | Mol Cell Endocrinol | Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | 2015 | Details |
| A20808 | 25721504 | Science | Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. | 2015 | Details |
| A20812 | 25716573 | J Diabetes Complications | Excess intake of fat and sugar potentiates epinephrine-induced hyperglycemia in male rats. | 2014 | Details |
| A20813 | 25716275 | Expert Rev Gastroenterol Hepatol | Management and diagnosis of fatty liver disease. | 2015 | Details |
| A20821 | 25713801 | Hepatobiliary Surg Nutr | Immunoregulation by lipids during the development of non-alcoholic steatohepatitis. | 2015 | Details |
| A20824 | 25711520 | Ann Transplant | The first Polish liver transplantation after Roux-en-Y gastric bypass surgery for morbid obesity: a case report and literature review. | 2015 | Details |
| A20825 | 25711346 | Clin Endocrinol (Oxf) | Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents. | 2015 | Details |
| A20829 | 25708291 | J Gastroenterol Hepatol | Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. | 2015 | Details |
| A20832 | 25706109 | Curr Drug Targets | Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism. | 2015 | Details |
| A20835 | 25703085 | J Hepatol | PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. | 2015 | Details |
| A20837 | 25701959 | Surg Obes Relat Dis | Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. | 2014 | Details |
| A20839 | 25701721 | Eur J Pharmacol | Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. | 2015 | Details |
| A20840 | 25697178 | Br J Nutr | Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. | 2015 | Details |
| A20841 | 25697114 | Med Hypotheses | Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH. | 2015 | Details |
| A20846 | 25690560 | Eur J Clin Invest | Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. | 2015 | Details |
| A20851 | 25686742 | Dig Dis Sci | Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population. | 2015 | Details |
| A20857 | 25683387 | Atherosclerosis | The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). | 2015 | Details |
| A20858 | 25683343 | Diabet Med | Practical approach to non-alcoholic fatty liver disease in patients with diabetes. | 2015 | Details |
| A20859 | 25681756 | Exp Mol Pathol | Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. | 2015 | Details |
| A20862 | 25681381 | Clin Infect Dis | Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy. | 2015 | Details |
| A20877 | 25670619 | Arab J Gastroenterol | Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats. | 2015 | Details |
| A20881 | 25667378 | Endocr Pract | RELATIVE CONTRIBUTIONS OF ECTOPIC LIVER AND ABDOMINAL FAT ACCUMULATION TO ARTERIAL STIFFNESS. | 2015 | Details |
| A20885 | 25664838 | Nutr Diabetes | Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. | 2015 | Details |
| A20887 | 25663786 | World J Gastroenterol | Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. | 2015 | Details |
| A20889 | 25661453 | Clin Gastroenterol Hepatol | Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A20899 | 25655252 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: a practical approach to treatment. | 2015 | Details |
| A20905 | 25654080 | Front Med (Lausanne) | Management of moderate to severe psoriasis in patients with metabolic comorbidities. | 2015 | Details |
| A20906 | 25651169 | Cell Metab | Turn up the heat: circulating serotonin tunes our internal heating system. | 2015 | Details |
| A20908 | 25649191 | Obes Res Clin Pract | Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. | 2015 | Details |
| A20909 | 25648740 | Eur J Nutr | Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults. | 2015 | Details |
| A20910 | 25648511 | Mar Drugs | Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats. | 2015 | Details |
| A20914 | 25646890 | J Hepatol | Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC. | 2015 | Details |
| A20922 | 25643684 | Gac Med Mex | [Hepatic steatosis (HS) as a factor associated with the presence of metabolic risk in schoolchildren and obese adolescents]. | 2014 | Details |
| A20926 | 25637246 | Mol Genet Metab | Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans. | 2015 | Details |
| A20931 | 25633064 | Arch Dis Child | Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. | 2015 | Details |
| A20948 | 25622927 | J Gastroenterol | Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. | 2015 | Details |
| A20951 | 25620624 | J Magn Reson Imaging | Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects. | 2015 | Details |
| A20953 | 25619540 | Curr Diabetes Rev | Is type 2 diabetes mellitus a predisposal cause for developing hepatocellular carcinoma? | 2015 | Details |
| A20957 | 25617860 | Atherosclerosis | A concise review of non-alcoholic fatty liver disease. | 2015 | Details |
| A20959 | 25617503 | J Hepatol | Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. | 2015 | Details |
| A20964 | 25616307 | Zhongguo Dang Dai Er Ke Za Zhi | [Research advances in pediatric nonalcoholic fatty liver disease]. | 2015 | Details |
| A20972 | 25609476 | Sci Rep | Potent effects of dioscin against obesity in mice. | 2015 | Details |
| A20978 | 25606030 | Case Rep Gastroenterol | A 25-year-old woman with type 2 diabetes and liver disease. | 2014 | Details |
| A20986 | 25601465 | Curr Mol Med | Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease. | 2015 | Details |
| A20989 | 25600030 | Curr Vasc Pharmacol | Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment. | 2015 | Details |
| A20994 | 25597287 | Exp Mol Pathol | A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity. | 2015 | Details |
| A20996 | 25595882 | J Hepatol | Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. | 2015 | Details |
| A20999 | 25591123 | J Pediatr Gastroenterol Nutr | Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement. | 2015 | Details |
| A21002 | 25587525 | Pediatr Gastroenterol Hepatol Nutr | The clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver disease. | 2014 | Details |
| A21004 | 25583095 | Clin Biochem | Laboratory assessment of cardiometabolic risk in overweight and obese children. | 2015 | Details |
| A21005 | 25581590 | Analyst | Vibrational signatures to discriminate liver steatosis grades. | 2015 | Details |
| A21009 | 25580206 | Frontline Gastroenterol | Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. | 2014 | Details |
| A21015 | 25575848 | Clin J Gastroenterol | Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. | 2015 | Details |
| A21016 | 25575598 | J Biol Chem | Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. | 2015 | Details |
| A21021 | 25573175 | Am J Physiol Gastrointest Liver Physiol | Chronic NOS inhibition accelerates NAFLD progression in an obese rat model. | 2015 | Details |
| A21025 | 25567295 | Clin Pediatr (Phila) | The full spectrum of hepatic steatosis in children. | 2015 | Details |
| A21028 | 25566190 | Front Endocrinol (Lausanne) | Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. | 2014 | Details |
| A21034 | 25564638 | BMJ Case Rep | Resolution of NASH with weight loss documented by hepatic MRI. | 2015 | Details |
| A21036 | 25563143 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. | 2015 | Details |
| A21037 | 25562616 | Endocrinology | Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. | 2015 | Details |
| A21039 | 25562147 | Cell Physiol Biochem | Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. | 2014 | Details |
| A21048 | 25556679 | Cell Mol Life Sci | Metabolic insights from zebrafish genetics, physiology, and chemical biology. | 2015 | Details |
| A21049 | 25554608 | Endokrynol Pol | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism. | 2014 | Details |
| A21050 | 25553983 | Eur J Intern Med | Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. | 2014 | Details |
| A21058 | 29201676 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Study of Demographic and Predictive Factors. | 2015 | Details |
| A21059 | 28596988 | J Diabetes Obes | NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population. | 2015 | Details |
| A21060 | 28356818 | J Med Biochem | Epidemiology and Natural History of NAFLD. | 2014 | Details |
| A21061 | 28356817 | J Med Biochem | Pediatric Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
| A21066 | 27214983 | Eksp Klin Gastroenterol | [INSULIN-LIKE GROWTH FACTOR-1: THE INFLUENCE ON THE LIVER FUNCTION AND RELATIONSHIPS WITH RESISTIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS]. | 2015 | Details |
| A21069 | 27188459 | Nat Rev Dis Primers | Nonalcoholic fatty liver disease. | 2015 | Details |
| A21076 | 25548491 | World J Gastroenterol | Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. | 2014 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21083 | 25544875 | World J Hepatol | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. | 2014 | Details |
| A21085 | 25544409 | Rev Esp Enferm Dig | Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients. | 2014 | Details |
| A21087 | 25543522 | Clin Res Hepatol Gastroenterol | Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different? | 2014 | Details |
| A21088 | 25543202 | Alcohol | A comparison of the cardiometabolic profile of black South Africans with suspected non-alcoholic fatty liver disease (NAFLD) and excessive alcohol use. | 2014 | Details |
| A21091 | 25541279 | Prostaglandins Leukot Essent Fatty Acids | Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis. | 2014 | Details |
| A21092 | 25540973 | Scand J Gastroenterol | Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. | 2014 | Details |
| A21096 | 25537957 | J Gastrointest Surg | Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. | 2014 | Details |
| A21097 | 25537833 | Diabetologia | Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. | 2014 | Details |
| A21099 | 25536648 | Ann Hepatol | Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD. | 2015 | Details |
| A21109 | 25533197 | Liver Int | Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. | 2015 | Details |
| A21110 | 25533124 | Biochim Biophys Acta | Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. | 2014 | Details |
| A21111 | 25533006 | Nutrients | Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. | 2014 | Details |